Professional Documents
Culture Documents
Atherogenesis
Non-infectious inflammation
oxidation of LDL
Oxidation of LDL’s
Thrombus formation
A B C
A
Signs and symptoms of CVA by involved cerebral artery
Contralateral hemiplegia
Aphasia
Hemonopia
Altered LOC
Vasomotor paresis and irritability
Hemiattention
Sensory impairment
a.3
Post. Cerebral artery
cell death
C
Ischemia penumbra region
excitotoxicity
Ca toxicity further inc. in NaCl into the cell
Cell death
BBB breakdown
Vasogenic edema
Inc. ICP
Brain herniation
Persistent ischemia
Irreversible brain damage
DEATH
ASSESSMENT AND
DIAGNOSTIC FINDINGS
Airway patency
cardiovascular Status (BP, HR, PR)
CT Scan-to determine if it is ischemic or hemorrhagic
12 lead ECG and carotid ultrasound – to identify the source of thrombi
or emboli
MEDICAL MANAGEMENT
Thrombolytic Therapy
thrombolytic agent
dissolving the blood clot that is blocking blood flow to the brain.
t-PA ( tissue-Plasminogen activator)
thrombolytic substance made naturally by the body
it works by binding to fibrin and converting plasminogen to plasmin which
stimulates fibrinolysis of the antherosclerotic lesion.
Initial Management:
CT Scanning
determination of wether the patient,s meets all he criteria of t-PA
Contraindications:
symptoms onset greater than 3 hors PTA
a patient who is anticoagulated
a patient who has had recent MI
a patient who has had any type of intracranial pathology (stroke, head
injury, trauma)
Assessments before the use of t-
PA (National Health Stroke Scale)
the patient is weighed to determine the dose of t-PA
minimum dose: 0.9mg/kg
maximum dose: 90 mg
loading dose: 10% of the calculated dose and administered over 1
minute
remaining dose is administered over via infusion pump
after it is completed, the line is flushed with 20 ml of Normal
Saline
Management for t-PA
>idiopathic >AVM
>aneurysm
>HPN
>head trauma
>atherosclerosis
hematoma swelling
Increased
ICP
spasms edema herniation hydrocephalus
decreased perfusion
ischemia
coma
death
>SUBARACHNOID HEMORRHAGE
A subarachnoid hemorrhage is sudden bleeding into the space (subarachnoid space)
between the inner layer (pia mater) and middle layer (arachnoid mater) of the
tissue covering the brain (meninges).
>INTRACEREBRAL HEMORRHAGE
An intracerebral hemorrhage is bleeding within the brain.
>ATRIOVENOUS MALFORMATION(AVM)
is an abnormal collection of blood vessels. Normally, oxygenated blood is
pumped by the heart through branching tubes called arteries to the brain,
where it enters a fine network of tiny vessels called capillaries. It is in these
capillary beds where the blood nourishes the tissues. Arterial-Venous
Malformations are areas that lack the tiny capillaries.
>ANEURYSM
is localized, blood-filled dilation (bulge) of a blood vessel caused by disease or
weakening of the vessel wall. Aneurysms most commonly occur in arteries at the base
of the brain (the circle of Willis) and in the aorta (the main artery coming out of the
heart), a so-called aortic aneurysm. The bulge in a blood vessel can burst and lead to
death at any time, much like a bulge in an over-inflated inner tube. The larger an
aneurysm becomes, the more likely it is to burst.
A.ANEURYMS B.AVM
CLINICAL MANIFESTATIONS
(Intracerebral)
severe headache
weakness
paralysis
numbness
loss of speech or vision
confusion
Nausea
vomiting
Seizures
loss of consciousness
ASSESSMENT AND DIAGNOSTIC FINDINGS
CTscan
-determine the size and location of hematoma
-presence or absence of venrticular blood
-hydrocepalus
magnetic resonance imaging (MRI)
-the procedures can also detect how much brain tissue has been damaged
and whether pressure is increased in other areas of the brain.
Spinal tap (lumbar puncture)
-can detect any blood in the cerebrospinal fluid.
-is not usually performed in intracerebral hemorrhge, it can cause
herniation of the brain
Cerebral angiography
-usually performed within 72 hours to confirm the diagnosis and to identify
the site of the aneurysm or arteriovenous malformation
Hunt-Hess classification system
MEDICAL MANAGEMENT
Managing Complications;
•cerebral hypoxia and decreased blood flow
-provide adequate oxygenation (supplemental oxygen)
-IV fluids for adequate hydration
•Vasospasm
-administering calcium channel blockers nimodipine
•Increased ICP
-ventricular catheter drainage
-mannitol
-lumbar puncture
•Systemic Hypertension
-antihypertensive therapy (labetalol ,nicardipine,
nitroprusside)
SURGICAL MANAGEMENT
-Altered level of consciousness Ineffective cerebral tissue Improved cerebral perfusion -Monitor for neurologic -Demonstrates intact
-Sluggish papillary reaction perfusion R/T bleeding deterioration occurring from neurologic status and normal
-Motor and sensory dysfunction recurrent bleeding ,increased vital signs and respiratory
-Cranial nerves ICP or vasospasm, patterns
deficits(extraoccular eye -V/S monitoring -Demonstrates normal sensory
movements, facial droop, -Papillary response and motor perception
presence of ptosis) function are checked hourly -Exhibits reduced anxiety level
-Speech difficulties and visual -Exhibits absence of
disturbance complications
-Head ache and nuchal rigidity
Disturbed sensory perception R/T Relief of sensory and -Providing non stimulating
medically imposed perceptual deprivation environment
restrictions(aneurysm precaution) -Prevent increases of ICP
elevation of head 15 - 30
-bed rest
-avoid activity that requires
exertion
-Prevent further bleeding
Anxiety R/T illness and/or Relief of anxiety and the -Keeping patient well informed
medically imposed absence of complications of the plan of care appropriate
restrictions(aneurysm precaution) reassurance